U.S. Protein Supplement Market Size Growing at 7.7% CAGR to Hit $3.58 billion by 2028

December 10, 2023 10:33 AM EST | By EIN Presswire
Follow us on Google News:

U.S. Protein Supplement Market was pegged at $1.92 billion in 2019, and is expected to reach $3.58 billion by 2028, growing at a CAGR of 7.7% from 2021 to 2028.

PORTLAND, OREGON, UNITED STATES, December 10, 2023 /EINPresswire.com/ -- Rise in awareness among people for health & fitness, surge in disposable income, and increase in demand for supplements from the Millennial population drive the growth of the U.S. Protein Supplement Market. By form, the RTD liquid segment is anticipated to manifest the highest CAGR of 8.7% during the forecast period. More and more people are more conscious about their dietary decisions, immunity, and weight gain, which favored the demand for protein supplements.

Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/12303

The U.S. Protein Supplement Market report includes an in-depth analysis of the prime market players such as ABH Pharma Inc., Abbott Laboratories, Glanbia Corp., Amway Corporation, Herbalife International of America Inc., GlaxoSmithKline, GNC Holdings, Bob's Red Mill, Nutiva Inc., and MusclePharm Corporation.

Covid-19 scenario:

Since the Covid-19 outbreak, people have become concerned about their health and wellness. More and more people are more conscious about their dietary decisions, immunity, and weight gain, which favored the demand for protein supplements.
Chronic illnesses such as diabetes and obesity could increase the chance of getting infected with Covid-19. Thus, the demand for protein supplements increased in the U.S. to combat such diseases and lead a healthier lifestyle.
Buy This Report (263 Pages PDF with Insights, Charts, Tables, and Figures): https://www.alliedmarketresearch.com/checkout-final/182756afce1b70cfb0fbfd35684739fd

U.S. Protein Supplement Market is segmented on the basis of type, form, source, gender, age group, and distribution channel.

Based on type, the soy protein segment is expected to register the highest CAGR of 8.8% during the forecast period. However, the whey protein segment held the largest share in 2019, accounting for nearly two-fifths of the market.

On the basis of form, the RTD liquid segment is anticipated to manifest the highest CAGR of 8.7% during the forecast period. However, the powder segment held the lion’s share in 2019, contributing to more than three-fourths of the market.

Request For Customization: https://www.alliedmarketresearch.com/request-for-customization/12303

Based on distribution channel, the e-commerce segment dominated the market in 2020, holding nearly one-fifth of the market. Moreover, the segment is expected to register the highest CAGR of 8.5% from 2021 to 2028.

Related Reports:
Carboxymethyl Cellulose Market: https://www.prnewswire.com/news-releases/carboxymethyl-cellulose-market-to-reach-2-43-bn-globally-by-2030-at-4-0-cagr-allied-market-research-301459319.html

Collagen Drinks Market: https://www.prnewswire.com/news-releases/canned-salmon-market-to-reach-5-43bn-globally-by-2030-at-5-1-cagr-allied-market-research-301478612.html

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK